중동 및 아프리카 활성 제약 성분(API) 시장 – 2030년까지의 산업 동향 및 예측

중동 및 아프리카 활성 약제 성분(API) 시장 분석 및 규모

기술 발전의 증가는 제조업체가 대량으로 API를 제공하고 소비자의 수요를 충족해야 하는 시장 참여자의 역량과 제조 기술을 향상시켜 중동 및 아프리카 활성 약제 성분(API) 시장의 성장을 촉진할 수 있습니다. 표준 이하 및 위조 약물의 가용성은 중동 및 아프리카 활성 약제 성분(API) 시장 수요를 방해하는 제약으로 작용하고 있습니다.

Data Bridge Market Research는 2022년에 6,889.76백만 달러였던 중동 및 아프리카 활성 약제 성분(API) 시장이 2030년까지 10,980.14백만 달러에 도달할 것으로 예상되며, 2023년에서 2030년까지의 예측 기간 동안 6.3%의 CAGR을 보일 것으로 분석했습니다. "소분자"는 높은 침투력으로 인해 규제 승인 수가 증가하고 새로운 소분자에 대한 연구 개발이 증가함에 따라 중동 및 아프리카 활성 약제 성분(API) 시장의 분자 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

중동 및 아프리카 활성 약제 성분(API) 시장 범위 및 세분화

Market Definition

Active pharmaceutical ingredients are the substance or combination of substances intended to be used in the manufacturing of a drug product, which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity. The final drug dosage form is formulated using the APIs and excipient but the APIs are formulated using the raw material which is known as intermediates. API intermediates are the kind of material that is produced in the process of API.

Middle East and Africa Active Pharmaceutical Ingredients (API) Market Dynamics

Drivers

• Increasing Demand for Generic Drugs

The Middle East and Africa have seen a rising demand for affordable healthcare and pharmaceuticals. Generic drugs, which require APIs, are often more cost-effective alternatives to branded medications. This has boosted the demand for APIs in the region. This increase in use of active pharmaceutical ingredients (API) in pharmaceutical drug production which will further act as driver that will lead to the growth of the active pharmaceutical ingredients (API) market in the above mentioned projected timeframe.

• Rise in Research and Development

Investments in research and development by pharmaceutical companies and API manufacturers in the Middle East and Africa are leading to the development of new drugs and therapies. This creates opportunities for API manufacturers to supply the necessary ingredients. This increase in the technological advancements is expected to accelerate the market growth. Furthermore, most of the active pharmaceutical ingredients (API) are used in pharmaceutical and biopharmaceutical companies because these companies are responsible for the production of medicines in all dosage forms such as solid, semi-solid and liquid.

• Rising Pharmaceutical Industry

The pharmaceutical industry in the Middle East and Africa has been expanding rapidly, driven by increasing populations, changing disease profiles, and government initiatives to improve healthcare access. As a result, local pharmaceutical companies are manufacturing more medications, increasing the demand for APIs, which can foster the demand for the active pharmaceutical ingredients (API) in the market.

Opportunity

• Rising Strategic Initiatives by Market Players

The key product launches, high concentration of market players or manufacturer's presence, and acquisition and partnerships among major players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, the rising demand for drugs has significantly heightened the need for new drug development via extensive clinical trials. Manufacturers are now focusing on remodelling their drug development processes in an attempt to cater to patient needs. Increasing advancement in technology and rising number of innovations along with rising product approvals which will further contribute by generating immense opportunities that will further expand the market's growth rate in the future. 

Restraint/Challenge

• Limited Domestic Production of API

The limited domestic API production capacity can lead to supply chain disruptions, especially during global crises or geopolitical tensions. Many countries in the Middle East and Africa rely heavily on API imports, often from countries such as India and China. This is expected to hinder the growth of Middle East and Africa pharmaceutical active pharmaceutical ingredients (API) market. Moreover, lack of skilled workforce will projected to become the biggest and foremost challenge for the growth of the market in the forecast period of 2023-2030.

This Middle East and Africa pharmaceutical active pharmaceutical ingredients (API) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa pharmaceutical active pharmaceutical ingredients (API) market Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2021, Merck KGaA signed a partnership with SaudiVax to help construct a multimodality biologics manufacturing facility to provide a more localized production infrastructure for the Middle East and North African region
• In November 2020, AlzChem Group AG had announced the expansion of the production of the nitriles which is one of the intermediates of the company. The company has decided to expand the production by 50%. The motive behind the company was to support the demand of the medicines and biocides. The nitrile production plant is based on the gas phase technology which has been optimized and validated by the company’s engineers. This expansion has helped the company to enhance their growth in the field of the intermediates which will help them to boost their production capacities
• In January 2018, AstraZeneca had signed an agreement with Cambrex who is the leading manufacturer of the small molecule APIs. The company has signed the agreement for the long term manufacturing of the products. This agreement helped the company to increase their product portfolio as the manufacturing is for the long term so it will boost the manufacturing skills of the company and at the end the revenues of the company will increase in end

Middle East and Africa Active Pharmaceutical Ingredients (API) Market Scope

The Middle East and Africa active pharmaceutical ingredients (API) market is segmented on the basis of molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency and therapeutic application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Molecule

• Small Molecule
• Large Molecule

Type

• Innovative Active Pharmaceutical Ingredients
• Generic Innovative Active Pharmaceutical Ingredients

Type of Manufacturer

• Captive API Manufacturer
• Merchant API Manufacturer

Synthesis

• Synthetic Active Pharmaceutical Ingredients
• Biotech Active Pharmaceutical Ingredients

Chemical Synthesis

• Acetaminophen
• Artemisinin
• Saxagliptin
• Sodium Chloride
• Ibuprofen
• Losartan Potassium
• Enoxaparin Sodium
• Rufinamide
• Naproxen
• Tamoxifen
• Others

Type of Drug

• Prescription Drugs
• Over-the-Counter

Usage

• Clinical
• Research

Potency

• Low-to-Moderate Potency Active Pharmaceutical Ingredients
• Potent-to-Highly Potent Active Pharmaceutical Ingredient

Therapeutic Application

• Cardiology
• CNS & Neurology
• Oncology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Other Therapeutic Application

Middle East and Africa Active Pharmaceutical Ingredients (API) Market Regional Analysis/Insights

The Middle East and Africa active pharmaceutical ingredients (API) market is analysed and market size insights and trends are provided by country, molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency and therapeutic application as mentioned above.

The countries covered in the Middle East and Africa active pharmaceutical ingredients (API) market report are South Africa, Saudi Arabia, U.A.E., Israel, Kuwait, Egypt, and Rest of Middle East and Africa

South Africa dominates the Middle East and Africa active pharmaceutical ingredients (API) market and is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to increase of easy product and easy availability of raw materials and increasing prevalence of various chronic disorders.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Middle East and Africa active pharmaceutical ingredients (API) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Middle East and Africa active pharmaceutical ingredients (API) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Middle East and Africa active pharmaceutical ingredients (API) market. The data is available for historic period 2015-2020.

Competitive Landscape and Active pharmaceutical ingredients (API) market Share Analysis

중동 및 아프리카 활성 제약 성분(API) 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 중동 및 아프리카 활성 제약 성분(API) 시장과 관련된 회사의 초점에만 관련이 있습니다.

중동 및 아프리카 활성 약제 성분(API) 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Teva Pharmaceutical Industries Ltd(이스라엘)
• Aspen Pharmacare Holdings Ltd(남아프리카 공화국)
• 히크마제약(영국)
• 에바파마(이집트)
• 알보젠(미국)
• 사노피(프랑스)
• Aurobindo Pharma(인도)
• BASF SE(독일)
• Vasudha Pharma(인도)
• 안양종합화학(중국)
• 산두제약화학(주)(중국)

SKU-61281